METHOTREXATE INJECTION BP
Google image searchProduct monograph
Active ingredient
methotrexate (methotrexate sodium), 25 MG/ML
DIN: 02327236
Dosage form(s): SOLUTION
Route(s) of administration: INTRACEREBROVENTRICULAR, INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Description: WITHOUT PRESERVATIVE (2 ML SINGLE-USE VIALS)
Schedule: Prescription
Company: ACCORD HEALTHCARE INC
Date: 26-AUG-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BA — Folic acid analogues (ATC, ATC/DDD)
- L01BA01 — METHOTREXATE (ATC/DDD)
Reference brand drug: Rheumatrex
Pharmaceutical standard: BP